FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat ...

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...

Limited (HK:0013) has released an update. HUTCHMED (China) Limited has announced that its New Drug Application for the ...

Dalnicastobart is under clinical development by Lyvgen Biopharma and currently in Phase I for Head And Neck Carcinoma.

oral cavity cancer, oropharyngeal cancer, hypopharyngeal cancer, laryngeal cancer, thymic carcinoma or urethral cancer. It is administered by intravenous drip route and subcutaneous route. The drug ...

(RTTNews) - Biopharmaceutical company Verastem Oncology (VSTM) Monday said that its treatment for a rare form of ovarian cancer has been given priority review by the Food and Drug Administration.

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

Research shows that caffeine inhibits the action of some antibiotics, such as Avelox (moxifloxacin), Noroxin (norfloxacin), ...

INR:1341. wingo ai tool Hausen introduces first-in-class oral antifungal drug Adeno-associated virus vector is not safe! Hemophilia patient developed liver cancer a ...

Alpelisib, we ran into a lot of toxicities, but they were all alpelisib toxicities. So a lower dose will be tested in the next cohort with elacestrant. And then capivasertib [Truqap] is in the early ...

Australian specialists, scientists and researchers are at the forefront of treatments that could change the lives of people ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...